2021
DOI: 10.1007/s40097-021-00394-w
|View full text |Cite
|
Sign up to set email alerts
|

Self-assembled membrane-polymer nanoparticles of top-notch tissue tolerance for the treatment of gastroesophageal reflux disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 73 publications
0
3
0
Order By: Relevance
“…Controlled release technology revolutionizes the delivery of active substances, offering precise targeting and sustained release, thereby maximizing treatment efficacy while minimizing potential side effects. By harnessing the potential of controlled release technology, healthcare professionals can optimize therapeutic interventions, providing a promising avenue for improving patient care and achieving superior treatment outcomes [ 80 ]. NPs can also serve as carriers for drug delivery purposes [ 29 ].…”
Section: Gastroesophageal Reflux Disease (Gerd)mentioning
confidence: 99%
See 1 more Smart Citation
“…Controlled release technology revolutionizes the delivery of active substances, offering precise targeting and sustained release, thereby maximizing treatment efficacy while minimizing potential side effects. By harnessing the potential of controlled release technology, healthcare professionals can optimize therapeutic interventions, providing a promising avenue for improving patient care and achieving superior treatment outcomes [ 80 ]. NPs can also serve as carriers for drug delivery purposes [ 29 ].…”
Section: Gastroesophageal Reflux Disease (Gerd)mentioning
confidence: 99%
“…In the case of GERD, this could involve delivering drugs that neutralize stomach acid or strengthen the LES directly to the affected site. In this study, researchers synthesized nanoparticles loaded with drugs specifically for treating GERD, taking advantage of the advantages offered by a controlled release approach [ 80 ]. Some studies showed that these NPs can slow down the release of these drugs in acidic environments such as the stomach [ 82 ].…”
Section: Gastroesophageal Reflux Disease (Gerd)mentioning
confidence: 99%
“…The past decade has witnessed significant advances in nanomaterial-based drug delivery, especially for tumor treatment 10 , 11 , 12 , 13 . As regards tumor chemotherapy in general, research in our laboratories on tumor-targeted chemotherapeutic nanomaterials have also contributed a great deal to recent advances on tumor chemotherapy.…”
Section: Chemotherapeutic Nanomaterialsmentioning
confidence: 99%